This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stocks Slump as Fed Sees 'Downside Risk'

NEW YORK ( TheStreet) -- Stocks closed near session lows on Wednesday after Federal Reserve policymakers said U.S. unemployment remains "elevated" and that "fiscal policy is restraining economic growth," adding that they are prepared to increase or reduce asset purchases as needed.

The S&P 500 dropped 0.93% to 1,582.70. The Dow Jones Industrial Average lost 0.94% to 14,700.95, while the Nasdaq slid 0.89% to 3,299.13.

"The Committee is prepared to increase or reduce the pace of its purchases to maintain appropriate policy accommodation as the outlook for the labor market or inflation changes."

The FOMC indicated it will continue its bond purchasing program, buying mortgage-backed securities at a pace of $40 billion per month in addition to longer-term Treasury securities at a pace of $45 billion a month. The Fed committee affirmed its target federal funds rate at 0% to 0.25%, noting that inflation has been running somewhat below the Committee's longer-run objective while longer-term inflation expectations have remained stable. The Committee anticipated that inflation over the medium term likely will run at or below its 2% objective.

The European Central Bank's rate announcement is scheduled for Thursday. Most economists in a Thomson Reuters poll are expecting a cut of 25 basis points to a new record low of 0.5%.

The latest employment numbers pointed to a slowdown in the economy with payroll processor ADP reporting that the private sector added 119,000 jobs in April vs. a downwardly-revised 131,000 in March. The number was below the consensus estimate of 150,000, according to Thomson Reuters.

Similarly, the ISM Manufacturing Index dipped to 50.7 in April from 51.3 in March, falling further than the 50.9 economists, on average, were expecting, according to Thomson Reuters. The construction spending number for March was also a disappointment, falling 1.7%, compared with forecasts for a 0.7% rise, and following an upwardly-revised increase of 1.5%.

As the biggest decliner in the S&P, Allergan (AGN - Get Report) plunged 13.1% after the company known for its Botox cosmetic treatment said that it would postpone two of its drug studies.

ADT Corp. (ADT - Get Report) slumped 6.9% to $40.64 after the home-security provider posted second-quarter earnings of 41 cents a share on revenue of $821 million, falling short of the average analyst earnings expectation of 43 cents a share on revenue of $823.48 million as non-recurring revenues declined 25.3%.

"The company's mix of newly installed systems continues to shift toward more ADT-owned systems, increasing deferred revenue and reducing current period installation revenue," ADT said in a statement.

Merck (MRK - Get Report) slid 2.8% to $45.69 after posting first-quarter revenue below estimates, as results took a hit from a stronger dollar that hurt sales abroad and generic competition for its Singulair asthma drug.

Humana (HUM - Get Report) popped 4.7% to $77.56 after the insurer raised its full-year earnings outlook to between $8.40 and $8.60 a share after reporting first-quarter earnings that beat analysts expectations and improved by 91% as Medicare Advantage enrollment and sales increased.

NBCUniversal parent Comcast (CMCSA - Get Report) rose 1.4% to $41.86 after reporting first-quarter earnings of 51 cents a share, beating estimates by a penny, and revenue that was a touch below expectations as a double-digit decline in broadcast sales was offset by strength in cable and theme parks.

Written by Andrea Tse and Joe Deaux in New York

>To contact the writer of this article, click here: Andrea Tse.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
ADT $34.48 4.77%
AGN $337.99 -0.44%
CMCSA $62.48 0.11%
HUM $184.41 -0.06%
MRK $58.54 1.77%


Chart of I:DJI
DOW 17,751.39 +121.12 0.69%
S&P 500 2,108.57 +15.32 0.73%
NASDAQ 5,111.7330 +22.5270 0.44%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs